Your Health Plan:
RUXIENCE (rituximab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Granulomatosis with polyangiitis and Microscopic Polyarteritis. RUXIENCE is a cd20-directed cytolytic antibody. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
RUXIENCE is not covered by . Cash price for 30-day supply is $100-1200.
Manufactuer Coupons are found: